Synthetic Discovery Focus
Human scFv and VHH discovery workflows designed around drug-discovery-oriented library logic.
Mission
Focused on Yeast Display Antibody Discovery
Who We Are
A focused CRO for synthetic antibody discovery
DuneX Biosciences helps teams discover and optimize antibody binders using synthetic yeast display libraries, FACS-based selection, and sequence-verified clone recovery.
FACS-Based Selection
Controlled selection pressure, expression-aware gating, and measurable enrichment across rounds.
Client-Ready Outputs
Sequence-verified clone panels, clear ranking, and practical recommendations for the next experiment.
Facility & Instrumentation
Facility and QC support for focused discovery work
Our Hayward lab supports yeast display discovery with flow-based selection, core molecular workflows, and practical QC checkpoints that help teams track campaign progress.
Flow Cytometry and Cell Sorting Platforms
Bio-Rad S3e cell sorter for flow-based selection and enrichment readouts.
Molecular & protein workflows
Basic molecular biology, yeast display handling, protein preparation, and clone recovery workflows.
QC checkpoints
NGS diversity checks, round-by-round enrichment tracking, and sequence-aware clone review.
Compliance & Confidentiality
Built for confidential discovery programs
Discovery work often starts before public disclosure. DuneX keeps project setup, communication, and data handling aligned around confidentiality from the first discussion.
NDA-first discussions
Confidential project details can be scoped after an NDA is in place.
Data segregation
Client materials, project records, and sequence files are organized with project-specific separation.
Insurance coverage
Operational coverage is maintained for client-facing discovery work.
Data retention SOP
Retention and handoff practices can be aligned during project setup.
Our History
Our Historical Milestones
DuneX has grown from platform concept to operational discovery partner through focused library design, facility buildout, and client-facing project work.
Platform concept and early development initiated
Library architecture design finalized
DuneX Biosciences established in Hayward, CA
Flow Cytometry & Cell Sorting Platform established
Launch of DuneX-NovaTM and Nano-CoreTM platforms
First commercial projects successfully initiated
Release of DuneX-NovaTM and NanoTM series libraries
Reached 50 validated binders milestone
Founder Bio
A concise view of the scientific path behind DuneX Biosciences.
Bruce Huang spent his undergraduate studies exploring yeast biology, working under Bonita Brewer and Matt Kaeberlein. He then investigated tyrosine kinase signaling in Jonathan Cooper's lab at Fred Hutchinson Cancer Center. During his Master's and PhD at McGill University under Morag Park, he investigated the structural mechanisms of Met deregulation in cancer. After gaining experience in big pharma, he founded DuneX Biosciences to tackle unmet needs in antibody discovery and protein engineering for biotech teams.
Supporting Biotech Teams Worldwide from the San Francisco Bay Area
Share your target format, project goal, and desired binder profile. We’ll help map the fastest practical path toward a focused yeast display discovery campaign.
Contact Us